GenMark Diagnostics (GNMK) – FDA
-
GenMark Diagnostics (GNMK) ePlex RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis
-
GenMark Diagnostics (GNMK) ePlex Respiratory Pathogen Panel 2 Receives EUA from FDA
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GNMK Stock Lookup